Press Releases

SOLCO HEALTHCARE US, INTRODUCES DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS, 150mg and 200mg

Nov 15, 2016 16:20

CRANBURY, NJ -- Solco Healthcare is proud to announce its FDA approval for Doxycycline Hyclate delayed-release tablets, 150mg and 200mg, which are AB-rated equivalents to Doryx® by Mayne Pharmaceutical. “This...

Read more

SOLCO HEALTHCARE U.S. ANNOUNCES THE APPROVAL OF GENERIC VFEND ® TABLETS IN THE UNITED STATES

Aug 12, 2016 10:59

CRANBURY, NJ – August 11, 2016 – Solco Healthcare U.S. is proud to announce that the U.S. Food and Drug Administration (FDA) approved its generic equivalent of Vfend ® Tablets...

Read more

Solco News

Here you will find useful healthcare related information and latest industry news, including exclusive content available only on Solco News.


Archives

2017 2016